RT @flaskworks: @theNCI @NCIResearchCtr Why did Dr Gilbert not mention $NWBO's DCVax under research at very productive SPORE centers @UCLAN…
RT @flaskworks: GBM treatments don't cross the blood brain barrier? That's false. Some participants at #CancerMoonshot forum are not up t…
RT @flaskworks: No innovation for GBM says moderator at #CancerMoonshot? Approve $NWBO's DCVax published in @JAMAOnc! https://t.co/UbQi4G…
RT @flaskworks: @theNCI @NCIResearchCtr Why did Dr Gilbert not mention $NWBO's DCVax under research at very productive SPORE centers @UCLAN…
RT @flaskworks: GBM treatments don't cross the blood brain barrier? That's false. Some participants at #CancerMoonshot forum are not up t…
RT @flaskworks: No innovation for GBM says moderator at #CancerMoonshot? Approve $NWBO's DCVax published in @JAMAOnc! https://t.co/UbQi4G…
RT @flaskworks: No innovation for GBM says moderator at #CancerMoonshot? Approve $NWBO's DCVax published in @JAMAOnc! https://t.co/UbQi4G…
RT @flaskworks: No innovation for GBM says moderator at #CancerMoonshot? Approve $NWBO's DCVax published in @JAMAOnc! https://t.co/UbQi4G…
RT @flaskworks: GBM treatments don't cross the blood brain barrier? That's false. Some participants at #CancerMoonshot forum are not up t…
RT @flaskworks: GBM treatments don't cross the blood brain barrier? That's false. Some participants at #CancerMoonshot forum are not up t…
RT @flaskworks: No innovation for GBM says moderator at #CancerMoonshot? Approve $NWBO's DCVax published in @JAMAOnc! https://t.co/UbQi4G…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @D_Carnival hopefully today you talk about NWBO and DC-Vax L and its phase 3 trial results publication in JAMA Oncology.…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu…
RT @glen_bwrhr42: @D_Carnival hopefully today you talk about NWBO and DC-Vax L and its phase 3 trial results publication in JAMA Oncology.…
@DCarnival46 @FlemmingBruce $nwbo Hopefully, you discuss NWBO and it's DCVAX-L vaccine for Glioblastoma today...possiblyu even the trials being conducted using DCVAX-L in UCLA under Dr. Linda Liau's auspices. Thanks. https://t.co/tillp7iApE
@D_Carnival hopefully today you talk about NWBO and DC-Vax L and its phase 3 trial results publication in JAMA Oncology. Thank you. $nwbo @FlemmingBruce https://t.co/tillp7iApE
RT @flaskworks: @StockMKTNewz There's only one stock in this market worth buying right now. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJ…
@CraigHorbinski That’s why you must turn the tumor from cold to hot. Good think is there is a successful phase 3 trial for #DCVAX from $NWBO that about to get approval… https://t.co/iQEounorzN
RT @flaskworks: @StockMKTNewz There's only one stock in this market worth buying right now. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJ…
RT @flaskworks: @StockMKTNewz There's only one stock in this market worth buying right now. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJ…
RT @flaskworks: @StockMKTNewz There's only one stock in this market worth buying right now. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJ…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
RT @eastvillagetwt: Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Amon…
Phase 3 results: $NWBO #DCvaxL Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination w/Extension of Survival Among Patients w/[BOTH] #NewlyDiagnosed & #Recurrent #Glioblastoma: A Phase 3 Prospective Externally Controlled Cohort Trial #CancerVacci
RT @albtur_mnymkrs: @MyPrecisionMed Please see the link below in @JAMAOnc for the P3 results of the #dcvax trial. In your report you refer…
RT @flaskworks: @DvdndDiplomats $NWBO will eventually pay dividends. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/m0FMW…
RT @albtur_mnymkrs: @MyPrecisionMed Please see the link below in @JAMAOnc for the P3 results of the #dcvax trial. In your report you refer…
RT @flaskworks: @DvdndDiplomats $NWBO will eventually pay dividends. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/m0FMW…
https://t.co/oQCfxXPFtQ $nwbo @alphavestcap
RT @albtur_mnymkrs: @MyPrecisionMed Please see the link below in @JAMAOnc for the P3 results of the #dcvax trial. In your report you refer…
RT @albtur_mnymkrs: @MyPrecisionMed Please see the link below in @JAMAOnc for the P3 results of the #dcvax trial. In your report you refer…
@MyPrecisionMed Please see the link below in @JAMAOnc for the P3 results of the #dcvax trial. In your report you refer to the dcvax P 1/2 trial. The trial has successfully concluded with statistically significant “landmark results”. https://t.co/zLO9S2Vo
RT @flaskworks: @DvdndDiplomats $NWBO will eventually pay dividends. https://t.co/UbQi4GbIF9 https://t.co/s8AGTeUJWn https://t.co/m0FMW…
RT @JAMAOnc: This study found that autologous tumor lystate-loaded dendritic cell vaccination plus standard of care (SOC) was associated wi…
@adamfeuerstein https://t.co/cMvKwiOy73. 1 Doctor who has ties to the helmet or 70 + Doctors with no conflicts of interest?
RT @eastvillagetwt: @metacollectiveG Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Am…
@metacollectiveG Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaA Phase 3 Prospective Externally Controlled Cohort Trial $NWBO #DCVaxL https
RT @flaskworks: @MinoSean Adam Feuerstein has done everything possible to destroy $NWBO's life-saving DCVax for glioblastoma patients. Lan…
RT @flaskworks: @MinoSean Adam Feuerstein has done everything possible to destroy $NWBO's life-saving DCVax for glioblastoma patients. Lan…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
@Doc_Hieu "There were 3 cases of intracranial edema (2 at grade 3; 1 at grade 2), 1 case of nausea (grade 3), and 1 case of lymph node infection (grade 3). There was no evidence of any auto-immune reactions or cytokine storm among patients who received DCV
@Doc_Hieu “Of 2151 total doses of DCVax-L administered, only 5 serious adverse events were deemed at least possibly related to the investigational treatment.” https://t.co/SgMIrc7H4H
RT @flaskworks: @MinoSean Adam Feuerstein has done everything possible to destroy $NWBO's life-saving DCVax for glioblastoma patients. Lan…
RT @MarciaJacobs13: Incredible that finally there is something real, something that can work, to give those diagnosed w/the worst of the wo…
RT @flaskworks: @mabbpah Landmark Trial Results are not failure yet every day we have Nevercure brain microwave shills hiding behind anonym…
RT @flaskworks: @mabbpah Landmark Trial Results are not failure yet every day we have Nevercure brain microwave shills hiding behind anonym…
RT @flaskworks: @mabbpah Landmark Trial Results are not failure yet every day we have Nevercure brain microwave shills hiding behind anonym…
RT @flaskworks: @mabbpah Landmark Trial Results are not failure yet every day we have Nevercure brain microwave shills hiding behind anonym…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
RT @eastvillagetwt: Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that…
Shorts can't stop $NWBO. They can play around the edges, pretend to know things they do not know or imply things that are false and for which they have no information, but the reality is, #DCVaxL is advancing toward regulators and it looks very good. htt
@YourselfOften Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaA Phase 3 Prospective Externally Controlled Cohort Trial https://t.co/AW4ElUA
RT @flaskworks: @Tiggersdad2 @GREEK__G0D @Keubiko @numbersguy91 @AnadarkoCapital Ah the usual suspects spreading lies about $NWBO. These t…
RT @MarciaJacobs13: Incredible that finally there is something real, something that can work, to give those diagnosed w/the worst of the wo…
RT @MarciaJacobs13: Incredible that finally there is something real, something that can work, to give those diagnosed w/the worst of the wo…
Incredible that finally there is something real, something that can work, to give those diagnosed w/the worst of the worst, #GBM, hope. Great way to start #BrainCancerAwarenessMonth #BrainCancer #Hope #Cure #research @LisainNJUSA @DCVAX_L @VitanzaNick @nw
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @KryptyPop: $NWBO
RT @KryptyPop: $NWBO
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: JAMA article is published and Dr. Linda Liau interview! $NWBO #DCVax-L 1. https://t.co/pfRDJSM1lP 2. https://t.co/O1rkNG8t…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…
RT @HenryMuney: Looking back at @JAMAOnc 2022, the acceptance rate of research articles was 8%. Publishing the #DCVax-L Phase 3 trial and r…